Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 study of S-288310 in patients with bladder cancer
jRCT2080220948Phase 2
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Dec 2009
- Modality
- Vaccines & Immunotherapeutics, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of S-288310 in bladder cancer, sponsored by Shionogi & Co., Ltd.
02
Drugs
S-288310
03
Conditions
bladder cancer
Beyond the preview
Go deeper on jRCT2080220948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220948.